Dr. Bennett is a surgical pathologist specializing in gynecologic pathology. Her research focuses on incorporating morphological, immunohistochemical, and molecular features to better characterize gynecologic neoplasms. Dr. Bennett's primary research interests include uterine mesenchymal neoplasms and ovarian epithelial carcinomas.
Massachusetts General Hospital
Boston, MA
Fellowship - Robert E. Scully Fellow in Gynecologic Pathology
2014
Penn State Hershey Medical Center
Hershey, PA
Residency - Anatomic Pathology
2013
University of Florida College of Medicine
Gainesville, FL
MD - Medicine
2010
University of Florida
Gainesville, FL
BS - Biochemistry and Molecular Biology
2005
STK11 adnexal tumor: A newly recognized entity that expands the spectrum of neoplasms associated with Peutz-Jeghers syndrome.
STK11 adnexal tumor: A newly recognized entity that expands the spectrum of neoplasms associated with Peutz-Jeghers syndrome. Gynecol Oncol. 2025 Apr 21; 197:25-26.
PMID: 40262437
Female Adnexal Tumor of Probable Wolffian Origin (FATWO): An Unusual Case With Development of Peritoneal Lesions After 3 Decades.
Female Adnexal Tumor of Probable Wolffian Origin (FATWO): An Unusual Case With Development of Peritoneal Lesions After 3 Decades. Int J Gynecol Pathol. 2025 Jan 15.
PMID: 40062785
STK11 Adnexal Tumor: Exploring the Association With Peutz-Jeghers Syndrome and its Distinction From Morphologic Mimickers.
STK11 Adnexal Tumor: Exploring the Association With Peutz-Jeghers Syndrome and its Distinction From Morphologic Mimickers. Adv Anat Pathol. 2025 Jan 01; 32(1):98-108.
PMID: 39225118
Uterine Inflammatory Myofibroblastic Tumors: p16 as a Surrogate for CDKN2A Deletion and Predictor of Aggressive Behavior.
Uterine Inflammatory Myofibroblastic Tumors: p16 as a Surrogate for CDKN2A Deletion and Predictor of Aggressive Behavior. Am J Surg Pathol. 2024 Jul 01; 48(7):813-824.
PMID: 38630911
The "Other" Uterine Mesenchymal Neoplasms: Recent Developments and Emerging Entities.
The "Other" Uterine Mesenchymal Neoplasms: Recent Developments and Emerging Entities. Adv Anat Pathol. 2024 Nov 01; 31(6):380-396.
PMID: 38623604
Inflammatory myofibroblastic tumor: a rare uterine mesenchymal neoplasm.
Inflammatory myofibroblastic tumor: a rare uterine mesenchymal neoplasm. Int J Gynecol Cancer. 2024 Jan 05; 34(1):171-173.
PMID: 37657821
Clinicopathologic Analysis and Molecular Profiling of Ovarian Steroid Cell Tumors.
Clinicopathologic Analysis and Molecular Profiling of Ovarian Steroid Cell Tumors. Am J Surg Pathol. 2023 12 01; 47(12):1398-1408.
PMID: 37796179
Inflammatory myofibroblastic tumor: a rare uterine mesenchymal neoplasm.
Inflammatory myofibroblastic tumor: a rare uterine mesenchymal neoplasm. Int J Gynecol Cancer. 2023 Sep 01.
PMID: 37657821
Diffuse Pediatric-type High-grade Glioma Arising in an Ovarian Mature Cystic Teratoma.
Diffuse Pediatric-type High-grade Glioma Arising in an Ovarian Mature Cystic Teratoma. Int J Gynecol Pathol. 2024 Jan 01; 43(1):90-96.
PMID: 37046379
Endometrial Carcinomas With Subclonal Loss of Mismatch Repair Proteins: A Clinicopathologic and Genomic Study.
Endometrial Carcinomas With Subclonal Loss of Mismatch Repair Proteins: A Clinicopathologic and Genomic Study. Am J Surg Pathol. 2023 05 01; 47(5):589-598.
PMID: 36866757